Cargando…
Systemic lupus erythematosus following human papillomavirus 9-valent vaccination
Autores principales: | Wan, Yuehua, Yang, Jinshui, Zhao, Yurong, Jin, Jingyu, Zhu, Jian, Li, Kunpeng, Zhang, Jianglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521746/ https://www.ncbi.nlm.nih.gov/pubmed/34924507 http://dx.doi.org/10.1097/CM9.0000000000001897 |
Ejemplares similares
-
A Broad Safety Assessment of the 9-Valent Human Papillomavirus Vaccine
por: Yih, W Katherine, et al.
Publicado: (2021) -
Extended surveillance to assess safety of 9-valent human papillomavirus vaccine
por: Sundaram, Maria E., et al.
Publicado: (2022) -
Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID‐19 vaccination
por: Wang, Huei‐Jing, et al.
Publicado: (2022) -
Lupus Erythematosus Panniculitis in Pregnancy and Antimalarials
por: Srivastava, Ankita
Publicado: (2016) -
TEN Like Lupus: A Rare Initial Presentation of Lupus Erythematosus
por: Kumar, Richa, et al.
Publicado: (2022)